DaVita Current Ratio 2010-2024 | DVA

Current and historical current ratio for DaVita (DVA) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. DaVita current ratio for the three months ending March 31, 2024 was 1.43.
DaVita Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-03-31 $3.68B $2.58B 1.43
2023-12-31 $3.14B $2.64B 1.19
2023-09-30 $3.14B $2.54B 1.24
2023-06-30 $3.00B $2.40B 1.25
2023-03-31 $3.04B $2.57B 1.19
2022-12-31 $3.16B $2.62B 1.20
2022-09-30 $3.20B $2.54B 1.26
2022-06-30 $3.26B $2.31B 1.41
2022-03-31 $3.13B $2.42B 1.29
2021-12-31 $3.17B $2.40B 1.32
2021-09-30 $3.84B $2.36B 1.63
2021-06-30 $3.98B $2.39B 1.67
2021-03-31 $3.87B $2.32B 1.67
2020-12-31 $3.15B $2.48B 1.27
2020-09-30 $3.43B $2.50B 1.37
2020-06-30 $5.78B $4.28B 1.35
2020-03-31 $4.02B $2.22B 1.81
2019-12-31 $3.69B $2.37B 1.56
2019-09-30 $4.00B $2.21B 1.81
2019-06-30 $6.39B $5.71B 1.12
2019-03-31 $9.23B $8.23B 1.12
2018-12-31 $8.42B $4.89B 1.72
2018-09-30 $8.93B $4.86B 1.84
2018-06-30 $9.09B $4.78B 1.90
2018-03-31 $8.67B $2.95B 2.94
2017-12-31 $8.77B $3.07B 2.86
2017-09-30 $4.03B $2.88B 1.40
2017-06-30 $4.02B $2.77B 1.45
2017-03-31 $4.60B $2.81B 1.64
2016-12-31 $4.00B $2.71B 1.47
2016-09-30 $4.26B $2.64B 1.61
2016-06-30 $4.50B $2.65B 1.70
2016-03-31 $4.20B $2.44B 1.72
2015-12-31 $4.50B $2.40B 1.88
2015-09-30 $4.74B $2.41B 1.97
2015-06-30 $4.78B $2.33B 2.05
2015-03-31 $4.30B $2.68B 1.61
2014-12-31 $3.64B $2.09B 1.74
2014-09-30 $4.18B $2.60B 1.61
2014-06-30 $4.16B $2.61B 1.60
2014-03-31 $3.71B $2.57B 1.45
2013-12-31 $3.47B $2.46B 1.41
2013-09-30 $3.38B $2.45B 1.38
2013-06-30 $3.13B $2.22B 1.41
2013-03-31 $3.19B $2.33B 1.37
2012-12-31 $2.89B $2.02B 1.43
2012-09-30 $2.33B $1.34B 1.74
2012-06-30 $2.18B $1.24B 1.76
2012-03-31 $2.37B $1.24B 1.91
2011-12-31 $2.29B $1.17B 1.97
2011-09-30 $2.37B $1.21B 1.97
2011-06-30 $2.51B $1.04B 2.43
2011-03-31 $2.73B $1.01B 2.71
2010-12-31 $2.62B $0.92B 2.84
2010-09-30 $2.26B $1.11B 2.04
2010-06-30 $2.27B $1.12B 2.03
2010-03-31 $2.46B $1.05B 2.35
2009-12-31 $2.30B $1.05B 2.20
2009-09-30 $2.31B $1.11B 2.07
2009-06-30 $2.23B $1.11B 2.01
2009-03-31 $2.03B $1.03B 1.98
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.472B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.159B 10.38
Quest Diagnostics (DGX) United States $15.253B 15.76
Elanco Animal Health (ELAN) United States $8.974B 23.28
Encompass Health (EHC) United States $8.595B 22.00
Chemed (CHE) United States $8.060B 24.99
Option Care Health (OPCH) United States $4.849B 18.35
RadNet (RDNT) United States $4.309B 89.74
Amedisys (AMED) United States $2.994B 21.21
Astrana Health (ASTH) United States $2.339B 31.63
LifeStance Health (LFST) United States $2.022B 0.00
Addus HomeCare (ADUS) United States $1.953B 27.94
U.S Physical Therapy (USPH) United States $1.465B 39.21
Pennant (PNTG) United States $0.681B 35.95
Aveanna Healthcare Holdings (AVAH) United States $0.508B 0.00
Atai Life Sciences (ATAI) Germany $0.213B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.019B 0.00
Novo Integrated Sciences (NVOS) United States $0.016B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00